New Delhi, Jun 11 (PTI) Drug firm Strides Pharma Science on Saturday said its subsidiary has received approval from the US health regulator to market Ibuprofen Oral Suspension, used for the treatment of pain and fever, in the American market.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/X8cyaxZ
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Strides gets USFDA nod for generic drug with 180-day exclusivity
https://ift.tt/j09VyhR
No comments:
Post a Comment